secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K/A
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001558370-23-010684
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences grants CEO Dayno 125,000 options in promotion compensation
------------------------------------------------------------------------------

- 125,000 options granted under 2020 Incentive Award Plan effective May 26, 2023.
- 50% of shares vest on May 25, 2025; remainder in 24 monthly installments starting June 25, 2025.
- Vesting conditioned on Dr. Dayno's continued service through each vesting date.
- Amendment provides details omitted from original April 24, 2023 8-K announcing Dayno's promotion to President and CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023010684/0001558370-23-010684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837023010684/hrmy-20230424x8ka.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer